Jeffrey Venstrom

Jeffrey Venstrom, Chief Medical Officer at GRAIL, pioneers innovative blood tests for early cancer detection. He discusses the revolutionary potential of free circulating tumor DNA testing and the urgent need for proactive cancer screening methods. The conversation delves into the significance of understanding cancer signals for targeted therapies and the transformative impact of technology in diagnostics. Venstrom emphasizes the importance of accessibility and education in cancer care, enabling informed patient decisions and improving outcomes.